The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis

Haematologica

Volumn 91, Issue 3, 2006, Pages 413-414

  Percy, Melanie J ^a   Jones, Frank G C ^a   Green, Anthony R ^b   Reilly, John T ^c   McMullin, Mary Frances ^d  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^d QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Idiopathic erythrocytosis; Myeloproliferative disorders; Polycythemia vera; V617F JAK2 mutation

Indexed keywords

ERYTHROPOIETIN; JANUS KINASE 2;

ADULT; ARTICLE; CONTROLLED STUDY; ERYTHROCYTOSIS; GENE MUTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; SCREENING TEST;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; JANUS KINASE 2; MIDDLE AGED; MUTATION; PHENYLALANINE; POLYCYTHEMIA; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; VALINE;

EID: 33645461067     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Baxter JE, Scott LM, Campbell PJ, East C, Fourouclas, N, Swanton, S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365:1054-61.
2. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling cause polythaemia vera. Nature 2005;434: 1144-8.
3. Jones AV, Kreil S, Zoi K, Waghorn K, Curtis C, Zhang L, et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 2005;106:2161-8.
4. Kralovics R, Passamonti F, Buser AS, Soon-Siong T, Tiedt R, Passweg JR, et al. A gain-of-function mutation or JAK2 in myeloproliferative disorders. N Eng J Med 2005;352:1779-90.
5. Percy MJ, McMullin MF, Jowitt SN, Potter M, Treacy M, Watson WH, et al. Chuvash-type congenital polycythemia in 4 families of Asian and western European ancestry. Blood. 2003;103:1097-9.
6. McMullin MF, Bareford D, Campbell P, Green AR, Harrison C, Hunt B, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis. Br J Haematol. 2005;130:17495.
7. Pearson TC, Messinezy M. The diagnostic criteria of polycythaemia rubra vera. Leuk Lymphoma 1996;22 Suppl 1:87-93.
8. Percy MJ, McMullin MF, Roques AW, Westwood NB, Acharya J, Hughes AE, et al. Erythrocytosis due to a mutation in the erythropoietin receptor gene. Br J Haematol 1998;100:407-10.
9. Pearson TC, Wetherley-Mein G. The course and complications of idiopathic erythrocytosis. Clin Lab Haematol 1979; 1:189-96.